Aug 28, 2024
Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference
Aug 08, 2024
Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
Jul 29, 2024
Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
May 29, 2024
Tarsus to Participate in Upcoming Investor Conferences
May 09, 2024
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
May 08, 2024
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
May 01, 2024
Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Apr 23, 2024
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
Mar 05, 2024
Tarsus to Participate at Upcoming Investor Conferences
Mar 05, 2024
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
Displaying 1 - 10 of 16